Mon 13 Jul 2009
United States Diabetes Care Devices Market Analysis & Forecasts
Posted by bharatbookgroup under market size , Market Share , report , research , Diabetes , Market Leaders , Market growth , Analysis , Demand Forecast , Market , market forecast , Market ReportUnited States Diabetes Care Devices Market Analysis & Forecasts
This United States Diabetes Care Devices Market Analysis & Forecasts report is an essential source for in-depth information and data relating to the US diabetes care devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the diabetes care devices market in the US.
Scope
- The report provides Diabetes care devices market information broken down into detailed categories and segments in the US.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.
Reasons to buy
- Gain a strong understanding of the diabetes care devices market in the US.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.
1 Table of Contents :
1.1 List of Tables 10
1.2 List of Figures 13
2 Introduction 14
2.1 What Is This Report About? 14
3 Executive Summary 15
4 Definitions of Markets Covered in This Report 16
4.1 Diabetes Care Devices 16
4.2 Glucose Monitoring Devices 16
4.2.1 Blood Glucose Meters 16
4.2.1.1 Traditional Glucose Meters 16
4.2.1.2 Continuous Glucose Monitoring Systems 16
4.2.2 Blood Glucose Strips 16
4.3 Insulin Delivery 16
4.3.1 InsulinPens 16
4.3.1.1 Reusable Insulin Pens 16
4.3.1.2 Disposable Insulin Pens 16
4.3.2 Insulin Syringes 17
4.3.3 Insulin Pumps 17
4.3.3.1 Traditional Insulin Pumps 17
4.3.3.2 Disposable Insulin Pumps 17
4.3.4 Traditional Insulin Pump Accessories 17
5 Healthcare Sector Review 18
5.1 Healthcare Expenditure 18
5.2 Healthcare Infrastructure 23
5.2.1 Healthcare Personnel Data 25
5.2.2 Healthcare Facilities Data 28
5.3 United States Healthcare Trade Statistics 30
6 Regulation System 31
6.1 Regulation System 31
6.2 Medical Equipment Approval Process 31
6.2.1 Pre-market Approval Process 32
6.2.2 Intended use and Indications for use 32
6.2.3 Predicate Device 33
6.2.4 Safe and Effective 33
6.2.5 Other Category Devices 35
6.2.6 Post-Market Approval Process 36
6.2.7 Compliance and Enforcement 36
6.2.8 Registration Fee 37
6.2.9 Approval Time 37
7 Pricing and Reimbursement 38
7.1 Government Policies 38
7.2 Private Insurance 39
7.3 Diagnosis Related Groups (DRG) 40
8 Distribution Structure 41
8.1 Distribution Structure 41
9 Diabetes Care Devices In United States 42
9.1 Diabetes Care Devices, United States, Overall Revenue ($ mn), 2000-2015 42
9.2 Diabetes Care Devices, United States, Category Volume (Units), 2000-2015 44
9.3 Diabetes Care Devices, United States, Cross-Category Analysis, 2000-2015 46
9.4 Diabetes Care Devices: Key Market Trends 47
9.4.1 Diabetes Care Devices: Growth Drivers 47
9.4.2 Diabetes Care Devices: Growth Restraints 47
9.5 Diabetes Care Devices, United States, Company Share (2006-2007) 48
9.6 Future Outlook 49
10 Glucose Monitoring In United States 50
10.1 Glucose Monitoring Overall Revenue (2000-2015) 50
10.1.1 Blood Glucose Meters Revenue (2000-2015) 52
10.2 Glucose Monitoring Overall Volume (2000-2015) 54
10.3 Glucose Monitoring, United States, Cross Segment Analysis, 2000-2015 56
10.4 Glucose Monitoring Average Price (2000-2015) 57
10.5 Glucose Monitoring Market Dynamics 58
10.5.1 Market Drivers 58
10.5.2 Market Restraints 58
10.6 Glucose Monitoring Distribution Share (2007-2008) 58
10.7 Glucose Monitoring, United States, Company Share (2006-2007) 59
11 Insulin Delivery In United States 61
11.1 Insulin Delivery Overall Revenue (2000-2015) 61
11.2 Insulin Delivery Overall Volume (2000-2015) 63
11.3 Insulin Delivery, United States, Cross Segment Analysis, 2000-2015\ 65
11.4 Insulin Delivery Average Price (2000-2015) 66
11.5 Insulin Delivery Market Dynamics 67
11.5.1 Market Drivers 67
11.5.2 Market Restraints 67
11.6 Insulin Delivery Distribution Share (2007-2008) 68
11.7 Insulin Delivery, United States, Company Share (2006-2007) 69
12 Overview of Key Companies in United States Diabetes Care Devices Market 71
12.1 LifeScan, Inc. Company Profile 71
12.1.1 Company Overview 71
12.1.2 LifeScan, Inc. Pipeline Products 71
12.1.2.1 LifeScan, Inc. Pipeline Products By Equipment Type 71
12.1.2.2 LifeScan, Inc. Pipeline Products By Development Stage 71
12.1.2.3 LifeScan, Inc. Pipeline Products By Therapy Area 72
12.1.2.4 LifeScan, Inc. Pipeline Products By Clinical Trials 72
12.1.2.5 LifeScan, Inc. Pipeline Products By News Summary 72
12.2 F. Hoffmann-La Roche Ltd. Company Profile 73
12.2.1 Company Overview 73
12.2.2 Value Chain Analysis 74
12.2.2.1 Manufacturing 74
12.2.2.2 Product Development 75
12.2.2.3 Sales and Marketing 76
12.2.3 F. Hoffmann-La Roche Ltd Pipeline Products 77
12.2.3.1 F. Hoffmann-La Roche Ltd Pipeline Products By Equipment Type 77
12.2.3.2 F. Hoffmann-La Roche Ltd Pipeline Products By Development Stage 77
12.2.3.3 F. Hoffmann-La Roche Ltd Pipeline Products By Therapy Area 77
12.3 Novo Nordisk A/S Company Profile 78
12.3.1 Company Overview 78
12.3.2 Novo Nordisk A/S Pipeline Products 78
12.3.2.1 Novo Nordisk A/S Pipeline Products by Equipment Type 78
12.3.2.2 Novo Nordisk A/S Pipeline Products by Development Stage 78
12.3.2.3 Novo Nordisk A/S Pipeline Products By Therapy Area 78
12.3.2.4 Novo Nordisk A/S Pipeline Products By Clinical Trials 79
12.4 Abbott Laboratories Company Profile 79
12.4.1 Company Overview 79
12.4.2 Value Chain Analysis 80
12.4.2.1 Manufacturing 80
12.4.2.2 Product Development 80
12.4.2.3 Sales and Marketing 82
12.4.3 Abbott Laboratories Pipeline Products 83
12.4.3.1 Abbott Laboratories Pipeline Products By Equipment Type 83
12.4.3.2 Abbott Laboratories Pipeline Products By Development Stage 83
12.4.3.3 Abbott Laboratories Pipeline Products By Therapy Area 83
12.4.3.4 Abbott Laboratories Pipeline Products By Clinical Trials 84
12.4.3.5 Abbott Laboratories Pipeline Products By News Summary 84
12.5 Bayer HealthCare AG Company Profile 85
12.5.1 Company Overview 85
12.5.2 Value Chain Analysis 86
12.5.2.1 Manufacturing 86
12.5.2.2 Product Development 87
12.5.2.3 Sales and Marketing 88
12.5.3 Bayer HealthCare AG Pipeline Products 88
12.5.3.1 Bayer HealthCare AG Pipeline Products By Equipment Type 88
12.5.3.2 Bayer HealthCare AG Pipeline Products By Development Stage 89
12.5.3.3 Bayer HealthCare AG Pipeline Products By Therapy Area 89
12.5.3.4 Bayer HealthCare AG Pipeline Products By News Summary 89
12.6 Medtronic, Inc. Company Profile 90
12.6.1 Company Overview 90
12.6.2 Value Chain Analysis 91
12.6.2.1 Manufacturing 91
12.6.2.2 Product Development 91
12.6.2.3 Sales and Marketing 92
12.6.3 Medtronic, Inc. Pipeline Products 93
12.6.3.1 Medtronic, Inc. Pipeline Products By Equipment Type 93
12.6.3.2 Medtronic, Inc. Pipeline Products By Development Stage 93
12.6.3.3 Medtronic, Inc. Pipeline Products By Therapy Area 94
12.6.3.4 Medtronic, Inc. Pipeline Products By Clinical Trials 94
12.7 Eli Lilly and Company Company Profile 95
12.7.1 Company Overview 95
12.7.2 Value Chain Analysis 96
12.7.2.1 Manufacturing 96
12.7.2.2 Product Development 97
12.7.2.3 Sales and Marketing 98
12.7.3 Eli Lilly and Company Pipeline Products 98
12.7.3.1 Eli Lilly and Company Pipeline Products by Equipment Type 98
12.7.3.2 Eli Lilly and Company Pipeline Products by Development Stage 99
12.7.3.3 Eli Lilly and Company Pipeline Products by Therapy Area 99
12.7.3.4 Eli Lilly and Company Pipeline Products by Clinical Trials 99
12.7.3.5 Eli Lilly and Company Pipeline Products by News Summary 99
12.8 Becton, Dickinson and Company Company Profile 100
12.8.1 Company Overview 100
12.8.2 Value Chain Analysis 101
12.8.2.1 Manufacturing 101
12.8.2.2 Product Development 102
12.8.2.3 Sales and Marketing 102
12.9 Abbott Diabetes Care, Inc. Company Profile 103
12.9.1 Company Overview 103
12.10 Home Diagnostics, Inc. Company Profile 103
12.10.1 Company Overview 103
12.11 Metrika, Inc. Company Profile 103
12.11.1 Company Overview 103
12.12 Nipro Diabetes Systems,Inc. Company Profile 104
12.12.1 Company Overview 104
12.13 AgaMatrix, Inc. Company Profile 105
12.13.1 Company Overview 105
12.13.2 AgaMatrix, Inc. Pipeline Products 105
12.13.2.1 AgaMatrix, Inc. Pipeline Products By Equipment Type 105
12.13.2.2 AgaMatrix, Inc. Pipeline Products By Development Stage 105
12.13.2.3 AgaMatrix, Inc. Pipeline Products By Therapy Area 105
12.14 DexCom, Inc. Company Profile 106
12.14.1 Company Overview 106
12.14.2 DexCom, Inc. Pipeline Products 106
12.14.2.1 DexCom, Inc. Pipeline Products By Equipment Type 106
12.14.2.2 DexCom, Inc. Pipeline Products By Development Stage 106
12.14.2.3 DexCom, Inc. Pipeline Products By Therapy Area 107
12.14.2.4 DexCom, Inc. Pipeline Products By News Summary 107
12.15 Freedom Meditech, Inc. Company Profile 108
12.15.1 Company Overview 108
12.15.2 Freedom Meditech, Inc. Pipeline Products 108
12.15.2.1 Freedom Meditech, Inc. Pipeline Products By Equipment Type 108
12.15.2.2 Freedom Meditech, Inc. Pipeline Products By Development Stage 108
12.15.2.3 Freedom Meditech, Inc. Pipeline Products By Therapy Area 108
12.16 GlucoLight Corporation Company Profile 109
12.16.1 Company Overview 109
12.16.2 GlucoLight Corporation Pipeline Products 109
12.16.2.1 GlucoLight Corporation Pipeline Products By Equipment Type 109
12.16.2.2 GlucoLight Corporation Pipeline Products By Development Stage 109
12.16.2.3 GlucoLight Corporation Pipeline Products By Therapy Area 109
12.16.2.4 GlucoLight Corporation Pipeline Products By Clinical Trials 110
12.16.2.5 GlucoLight Corporation Pipeline Products By News Summary 110
12.17 iSense Corporation Company Profile 111
12.17.1 Company Overview 111
12.17.2 iSense Corporation Pipeline Products 111
12.17.2.1 iSense Corporation Pipeline Products By Equipment Type 111
12.17.2.2 iSense Corporation Pipeline Products By Development Stage 111
12.17.2.3 iSense Corporation Pipeline Products By Therapy Area 112
12.17.2.4 iSense Corporation Pipeline Products By News Summary 112
12.18 Sensys Medical, Inc. Company Profile 113
12.18.1 Company Overview 113
12.18.2 Sensys Medical, Inc. Pipeline Products 113
12.18.2.1 Sensys Medical, Inc. Pipeline Products By Equipment Type 113
12.18.2.2 Sensys Medical, Inc. Pipeline Products By Development Stage 113
12.18.2.3 Sensys Medical, Inc. Pipeline Products By Therapy Area 114
12.18.2.4 Sensys Medical, Inc. Pipeline Products By Clinical Trials 114
13 Financial Deals Landscape 115
13.1 Acquisition 115
13.1.1 Mediscience Technology Acquires SensiVida Medical Systems 115
13.2 Partnerships 116
13.2.1 Edwards Lifesciences Enters Into an Agreement with DexCom 116
14 Recent Developments 117
14.1 Strategy and Business Planning 117
14.1.1 Mar 10, 2009: Medtronic MiniMed Considers San Antonio and Kansas City for Expansion 117
14.2 Legal and Regulatory 118
14.2.1 Mar 11, 2009: Medtronic Announces Dismissal of Lawsuit 118
14.2.2 Jan 07, 2009: BD Settles Lawsuit with Ultimed 118
14.2.3 Nov 25, 2008: Bayer HealthCare Reaches $97.5 Million Settlement With US DOJ 118
14.3 Government and Public Interest 119
14.3.1 Mar 19, 2009: FDA: Insulin Pens and Insulin Cartridges Must Not Be Shared 119
14.3.2 Nov 11, 2008: New Nanomaterial Could Be Breakthrough for Implantable Medical Devices 120
14.3.3 Nov 04, 2008: Georgia Researchers to Study Impact Of Insulin Pump 120
14.3.4 Oct 27, 2008: Researchers Developing Artificial Pancreas to Treat Type 1 Diabetics 122
14.4 Product News 123
14.4.1 Mar 25, 2009: Smiths Medical Announces Intent to Stop Selling Deltec Cozmo Insulin Pumps 123
14.4.2 Feb 26, 2009: FDA Approves Sanofi-aventis’ Apidra SoloSTAR 123
14.4.3 Feb 11, 2009: Insulet Corporation’s OmniPod System Selected as Finalist for the 2009 Edison Best New Product Awards 124
14.4.4 Feb 09, 2009: ARKRAY Announces FDA Approval to Market GLUCOCARD 01-mini Blood Glucose Monitoring System 124
14.4.5 Dec 23, 2008: Generex Receives Approval for Oral-lyn 125
14.4.6 Nov 13, 2008: Echo Therapeutics to Present Clinical Study Results Of Its Symphony Transdermal Continuous Glucose Monitoring System 125
14.4.7 Oct 02, 2008: Tosoh G8 HPLC Analyzer for Diabetes Monitoring and HbA1c Testing Cleared By FDA 125
15 Appendix 127
15.1 GlobalData Research Methodology 127
15.2 Coverage 128
15.3 Secondary Research 129
15.4 Primary Research 129
15.5 Models 130
15.6 Forecasts 130
15.7 Expert Panel Validation 131
15.8 Currency Conversion 132
15.9 Contact Us 133
15.10 Disclaimer 133
1.1 List of Tables
Table 1: United States Healthcare Expenditure, 2003-2010 19
Table 2: United States Healthcare Expenditure by Age (per person), 2000-2003 20
Table 3: United States Healthcare Expenditure by Sex (per person), 2000-2003 20
Table 4: United States Healthcare Expenditure by Race (per person), 2000-2003 21
Table 5: United States Personal Healthcare Expenditure by Type, 2000-2004 21
Table 6: United States Personal Healthcare Expenditure by Source, 2000-2004 22
Table 7: Total Number of Doctors in the United States, 2003-2010 25
Table 8: Number of Doctors by Specialty in the United States, 2003-2010 26
Table 9: Doctors by Region (Number per 10,000 Civilian Population), 2002-2004 27
Table 10: Doctors by Region (Number per 10,000 Civilian Population), 2002-2004 (Cont.) 28
Table 11: Total Hospitals in the United States, 2000-2004 28
Table 12: Community Hospitals by Number of Beds in the United States, 2000-2004 29
Table 13: Number of Hospital Beds in the United States, 2000-2004 29
Table 14: Number of Hospital Beds by Range in the United States, 2000-2004 29
Table 15: United States Healthcare Trade Statistics, 2001-2006 30
Table 16: Medical Equipment Registration Fee in United States, 2007 37
Table 17: Medical Device Approval Time in United States, 2004 37
Table 18: Diabetes Care Devices, United States, Overall Revenue ($ mn), Historic, 2000-2008 42
Table 19: Diabetes Care Devices, United States, Overall Revenue ($ mn), Forecast, 2008-2015 43
Table 20: Diabetes Care Devices, United States, Category Volume (Units), Historic, 2000-2008 44
Table 21: Diabetes Care Devices, United States, Category Volume (Units), Forecast, 2008-2015 45
Table 22: Diabetes Care Devices, United States, Portfolio Analysis, 2000-2015 46
Table 23: Diabetes Care Devices, United States, Company Share by Revenue ($ mn), 2006-2007 48
Table 24: Glucose Monitoring, United States, Revenue ($ mn) by Segment, Historic, 2000-2008 50
Table 25: Glucose Monitoring, United States, Revenue ($ mn) by Segment, Forecast, 2008-2015 51
Table 26: Blood Glucose Meters, United States, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 52
Table 27: Blood Glucose Meters, United States, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 53
Table 28: Glucose Monitoring, United States, Volume (Units), Historic, 2000-2008 54
Table 29: Glucose Monitoring, United States, Volume (Units), Forecast, 2008-2015 55
Table 30: Glucose Monitoring, United States, Cross Segment Analysis, 2000-2015 56
Table 31: Glucose Monitoring, United States, Average Price ($), Historic, 2000-2008 57
Table 32: Glucose Monitoring, United States, Average Price ($), Forecast, 2008-2015 57
Table 33: Glucose Monitoring, United States, Distribution Share by Revenue ($mn), 2007-2008 58
Table 34: Glucose Monitoring, United States, Company Share by Revenue ($ mn), 2006-2007 59
Table 35: Insulin Delivery, United States, Revenue ($ mn) by Segment, Historic, 2000-2008 61
Table 36: Insulin Delivery, United States, Revenue ($ mn) by Segment, Forecast, 2008-2015 62
Table 37: Insulin Delivery, United States, Volume (Units), Historic, 2000-2008 63
Table 38: Insulin Delivery, United States, Volume (Units), Forecast, 2008-2015 64
Table 39: Insulin Delivery, United States, Cross Segment Analysis, 2000-2015 65
Table 40: Insulin Delivery, United States, Average Price ($), Historic, 2000-2008 66
Table 41: Insulin Delivery, United States, Average Price ($), Forecast, 2008-2015 66
Table 42: Insulin Delivery, United States, Distribution Share by Revenue ($mn), 2007-2008 68
Table 43: Insulin Delivery, United States, Company Share by Revenue ($ mn), 2006-2007 69
Table 44: LifeScan, Inc. Pipeline Products by Equipment Type 71
Table 45: LifeScan, Inc. Pipeline Products By Development Stage 71
Table 46: LifeScan, Inc. Pipeline Products By Therapy Area 72
Table 47: LifeScan, Inc. Pipeline Products By Clinical Trials 72
Table 48: LifeScan, Inc. Pipeline Products By News Summary 72
Table 49: F. Hoffmann-La Roche Ltd Pipeline Products by Equipment Type 77
Table 50: F. Hoffmann-La Roche Ltd Pipeline Products By Development Stage 77
Table 51: F. Hoffmann-La Roche Ltd Pipeline Products By Therapy Area 77
Table 52: Novo Nordisk A/S Pipeline Products by Equipment Type 78
Table 53: Novo Nordisk A/S Pipeline Products By Development Stage 78
Table 54: Novo Nordisk A/S Pipeline Products By Therapy Area 78
Table 55: Novo Nordisk A/S Pipeline Products By Clinical Trials 79
Table 56: Abbott Laboratories Pipeline Products by Equipment Type 83
Table 57: Abbott Laboratories Pipeline Products By Development Stage 83
Table 58: Abbott Laboratories Pipeline Products By Therapy Area 83
Table 59: Abbott Laboratories Pipeline Products By Clinical Trials 84
Table 60: Abbott Laboratories Pipeline Products By News Summary 84
Table 61: Bayer HealthCare AG Pipeline Products by Equipment Type 88
Table 62: Bayer HealthCare AG Pipeline Products By Development Stage 89
Table 63: Bayer HealthCare AG Pipeline Products By Therapy Area 89
Table 64: Bayer HealthCare AG Pipeline Products By News Summary 89
Table 65: Medtronic, Inc. Pipeline Products by Equipment Type 93
Table 66: Medtronic, Inc. Pipeline Products By Development Stage 93
Table 67: Medtronic, Inc. Pipeline Products By Therapy Area 94
Table 68: Medtronic, Inc. Pipeline Products By Clinical Trials 94
Table 69: Eli Lilly and Company Pipeline Products by Equipment Type 99
Table 70: Eli Lilly and Company Pipeline Products by Development Stage 99
Table 71: Eli Lilly and Company Pipeline Products by Therapy Area 99
Table 72: Eli Lilly and Company Pipeline Products by Clinical Trials 99
Table 73: Eli Lilly and Company Pipeline Products by News Summary 99
Table 74: AgaMatrix, Inc. Pipeline Products by Equipment Type 105
Table 75: AgaMatrix, Inc. Pipeline Products By Development Stage 105
Table 76: AgaMatrix, Inc. Pipeline Products By Therapy Area 105
Table 77: DexCom, Inc. Pipeline Products by Equipment Type 106
Table 78: DexCom, Inc. Pipeline Products By Development Stage 106
Table 79: DexCom, Inc. Pipeline Products By Therapy Area 107
Table 80: DexCom, Inc. Pipeline Products By News Summary 107
Table 81: Freedom Meditech, Inc. Pipeline Products by Equipment Type 108
Table 82: Freedom Meditech, Inc. Pipeline Products By Development Stage 108
Table 83: Freedom Meditech, Inc. Pipeline Products By Therapy Area 108
Table 84: GlucoLight Corporation Pipeline Products by Equipment Type 109
Table 85: GlucoLight Corporation Pipeline Products By Development Stage 109
Table 86: GlucoLight Corporation Pipeline Products By Therapy Area 109
Table 87: GlucoLight Corporation Pipeline Products By Clinical Trials 110
Table 88: GlucoLight Corporation Pipeline Products By News Summary 110
Table 89: iSense Corporation Pipeline Products by Equipment Type 111
Table 90: iSense Corporation Pipeline Products By Development Stage 111
Table 91: iSense Corporation Pipeline Products By Therapy Area 112
Table 92: iSense Corporation Pipeline Products By News Summary 112
Table 93: Sensys Medical, Inc. Pipeline Products by Equipment Type 113
Table 94: Sensys Medical, Inc. Pipeline Products By Development Stage 113
Table 95: Sensys Medical, Inc. Pipeline Products By Therapy Area 114
Table 96: Sensys Medical, Inc. Pipeline Products By Clinical Trials 114
Table 97: Mediscience Technology Acquires SensiVida Medical Systems 115
Table 98: Edwards Lifesciences Enters Into An Agreement With DexCom 116
Table 99: USD to Local Currency, Average Exchange Rate 2008 132
1.2 List of Figures
Figure 1: United States, Healthcare Expenditure by Source, 2003 19
Figure 2: United States, Healthcare Infrastructure, Top Level View, 2007 24
Figure 3: Healthcare Expenses Segmentation by End User, 2003 25
Figure 4: Medical Equipment Approval Process in the United States, 2007 32
Figure 5: PMA Approval Process in the United States, 2007 34
Figure 6: The 510(k) Approval Process for Medical Devices in the United States, 2007 35
Figure 7: Reimbursement Structure in the United States, 2007 40
Figure 8: Distribution Structure of Medical Equipment in the United States, 2006 41
Figure 9: Diabetes Care Devices, United States, Overall Revenue ($ mn), Historic, 2000-2008 42
Figure 10: Diabetes Care Devices, United States, Overall Revenue ($ mn), Forecast, 2008-2015 43
Figure 11: Diabetes Care Devices, United States, Category Volume (Units), Historic, 2000-2008 44
Figure 12: Diabetes Care Devices, United States, Category Volume (Units), Forecast, 2008-2015 45
Figure 13: Diabetes Care Devices, United States, Cross-Category Analysis, 2000-2015 46
Figure 14: Diabetes Care Devices, United States, Company Share (%), 2007 48
Figure 15: Glucose Monitoring, United States, Revenue ($ mn) by Segment, Historic, 2000-2008 50
Figure 16: Glucose Monitoring, United States, Revenue ($ mn) by Segment, Forecast, 2008-2015 51
Figure 17: Blood Glucose Meters, United States, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 52
Figure 18: Blood Glucose Meters, United States, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 53
Figure 19: Glucose Monitoring, United States, Cross Segment Analysis, 2000-2015 56
Figure 20: Glucose Monitoring, United States, Company Share (%), 2007 59
Figure 21: Insulin Delivery, United States, Revenue ($ mn) by Segment, Historic, 2000-2008 61
Figure 22: Insulin Delivery, United States, Revenue ($ mn) by Segment, Forecast, 2008-2015 62
Figure 23: Insulin Delivery, United States, Cross Segment Analysis, 2000-2015 65
Figure 24: Insulin Delivery, United States, Company Share (%), 2007 69
Figure 25: F. Hoffmann-La Roche Ltd Value Chain Analysis 74
Figure 26: Abbott Laboratories Value Chain Analysis 80
Figure 27: Bayer HealthCare AG Value Chain Analysis 86
Figure 28: Medtronic, Inc. Value Chain Analysis 91
Figure 29: Eli Lilly and Company Value Chain Analysis 96
Figure 30: Becton, Dickinson and Company Value Chain Analysis 101
Figure 31: GlobalData Methodology 128
To know more and to buy a copy of your report please visit
http://www.bharatbook.com/Market-Research-Reports/United-States-Diabetes-Care-Devices-Market-Analysis-and-Forecasts.html